Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA reform stalling in Senate as August recess approaches.

This article was originally published in The Tan Sheet

Executive Summary

FDA REFORM BILL UNLIKELY TO HIT SENATE FLOOR BEFORE AUGUST RECESS despite being on Senate Majority Leader Lott's (R-Miss.) list of legislative priorities for the month of July. Lott is understood to have canceled plans to bring the bill to the floor, however, because of a failure in the Senate to reach a final agreement on Sen. Kassebaum's (R-Kan.) S 1477. The Senate Majority Leader's office indicates that the floor calendar for the week of July 29 is filled by work on appropriations legislation.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085846

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel